Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

AHT release initial results from IVDD project
Dachshund
Dachschunds are 10-12 times more likely to suffer from IVDD than any other breed.

No link found between chromosome 12 and "herniated" cases vs control

Initial results released from the Animal Health Trusts' Dachshund Intervertebral Disease (IVDD) genetics project have revealed that no correlation has been found between the Chromosome 12 region, previously identified by Danish researchers, and the Dachshund Breed Council's "herniated" cases vs controls.  

Herniation of the intervertebral disc (a "slipped disc") is a significant problem in dogs and a common cause of pain and difficulty walking. Although dogs of any breed can be affected, Dachshunds are 10-12 times more likely to suffer than other breeds, indicating that the disorder probably has a genetic component and mutations in specific gene(s) play a role in the development of the condition.

Working in collaboration with the Dachshund Breed Council, the AHT launched a project last July to investigate the genetics of IVDD in Dachschunds, with the aim of developing a genetics tool that breeders can use to reduce the prevalence of the disease.  

The project was set up to build on the work carried out in 2011 by the University of Copenhagen, which used dogs with calcifications (cases) and dogs without calcifications (controls). The findings from this study gave convincing evidence that genes on chromosome 12 affect the development of intervertebral disc calcification in the Dachshund.

The AHT's project was significantly different to the Copenhagen study, in that it used dogs that have suffered herniations in the lumbar region, and dogs that have never suffered back problems.  

Although they are disappointed with the results, the Dachshund Breed Council said that they always knew there were risks because they were testing a slightly different hypothesis to the Danes.

Cathryn Mellersh, head of molecular genetics at the AHT, said "Moving forward we think the most appropriate next step is to undertake a genome-wide scan that will involve typing a set of cases and controls for around 200,000 markers spanning the dogs’ DNA to try to identify a region of the canine DNA associated with IVDD.

"For this genome scan we need to ensure that we have a robust set of cases, so we will work with a neurologist to review cases to create a tight case definition, as we have previously done for complex conditions in the dog, such as epilepsy."     

Agreeing that further work would be worthwhile, the Dachshund Breed Council added:  "This issue is far too important for the breed's health for us not to explore it further using the technology available." 

 

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.